Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares traded 15.28% higher at $0.31 on Wall Street last session.
In accordance with the data, 1 analysts cover Neptune Wellness Solutions Inc. (NASDAQ:NEPT). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $21.94 and a low of $21.94, we find $21.94. Given the previous closing price of $0.27, this indicates a potential upside of 8025.93 percent. NEPT stock price is now -62.51% away from the 50-day moving average and -89.58% away from the 200-day moving average. The market capitalization of the company currently stands at $2.44M.
It has been rated a hold by 1 analysts and a buy by 0. Brokers who have rated the stock have averaged $21.94 as their price target over the next twelve months.
, while ‘ROTH Capital’ rates the stock as ‘Buy’.
A total of 8.19% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in NEPT stock. A new stake in Neptune Wellness Solutions Inc. shares was purchased by VIRTU FINANCIAL LLC during the first quarter worth $13,000. TWO SIGMA SECURITIES, LLC invested $9,000 in shares of NEPT during the first quarter. In the first quarter, CITADEL ADVISORS LLC acquired a new stake in Neptune Wellness Solutions Inc. valued at approximately $9,000. GOLDMAN SACHS GROUP INC acquired a new stake in NEPT for approximately $6,000. In total, there are 12 active investors with 28.29% ownership of the company’s stock.
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) opened at $0.2850 on Thursday. During the past 12 months, Neptune Wellness Solutions Inc. has had a low of $0.23 and a high of $19.64. The fifty day moving average price for NEPT is $0.8316 and a two-hundred day moving average price translates $2.9927 for the stock.
The latest earnings results from Neptune Wellness Solutions Inc. (NASDAQ: NEPT) was released for Jun, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.67, beating analysts’ expectations of -$1.71 by 1.04. This compares to -$2.53 EPS in the same period last year. The company reported revenue of $11.99 million for the quarter, compared to $12.52 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.25 percent. For the current quarter, analysts expect NEPT to generate $9.19M in revenue.
Neptune Wellness Solutions Inc.(NEPT) Company Profile
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.